BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 35644719)

  • 1. To what degree are health insurance enrollees in the Netherlands aware of the restrictive conditions attached to their policies?
    van der Hulst FJP; Holst L; Brabers AEM; de Jong JD
    Health Policy; 2022 Jul; 126(7):693-703. PubMed ID: 35644719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How is enrollees' trust in health insurers associated with choosing health insurance?
    van der Hulst FJP; Brabers AEM; de Jong JD
    PLoS One; 2023; 18(11):e0292964. PubMed ID: 37917768
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An assessment of the Dutch experience with health insurers acting as healthcare advisors.
    Victoor A; Brabers AEM; van Esch TEM; de Jong JD
    PLoS One; 2019; 14(11):e0224829. PubMed ID: 31703085
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The relation between trust and the willingness of enrollees to receive healthcare advice from their health insurer.
    van der Hulst FJP; Brabers AEM; de Jong JD
    BMC Health Serv Res; 2023 Jan; 23(1):52. PubMed ID: 36653840
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health plan choice in the Netherlands: restrictive health plans preferred by young and healthy individuals.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    Health Econ Policy Law; 2017 Jul; 12(3):345-362. PubMed ID: 28290918
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The relation between selective contracting and healthcare expenditures in private health insurance plans in the United States.
    van den Broek-Altenburg EM; Atherly AJ
    Health Policy; 2020 Feb; 124(2):174-182. PubMed ID: 31932076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Preferred providers and the credible commitment problem in health insurance: first experiences with the implementation of managed competition in the Dutch health care system.
    Boonen LH; Schut FT
    Health Econ Policy Law; 2011 Apr; 6(2):219-35. PubMed ID: 21122187
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Advice from the health insurer as a channelling strategy: a natural experiment at a Dutch health insurance company.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    BMC Health Serv Res; 2018 Nov; 18(1):832. PubMed ID: 30400978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prices and market power in mental health care: Evidence from a major policy change in the Netherlands.
    Brouns C; Douven R; Kemp R
    Health Econ; 2021 Apr; 30(4):803-819. PubMed ID: 33502788
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Netherlands: health system review.
    Schäfer W; Kroneman M; Boerma W; van den Berg M; Westert G; Devillé W; van Ginneken E
    Health Syst Transit; 2010; 12(1):v-xxvii, 1-228. PubMed ID: 21132996
    [TBL] [Abstract][Full Text] [Related]  

  • 11. What can Europe learn from the managed care backlash in the United States?
    Duijmelinck D; van de Ven W
    Health Policy; 2016 May; 120(5):509-18. PubMed ID: 27055353
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ranking sources of hospital quality information for orthopedic surgery patients: consequences for the system of managed competition.
    Bes RE; van den Berg B
    Patient; 2013; 6(2):75-80. PubMed ID: 23549928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Citizen engagement in healthcare procurement decision-making by healthcare insurers: recent experiences in the Netherlands.
    Brito Fernandes Ó; Bos V; Klazinga N; Kringos D
    Health Res Policy Syst; 2022 Dec; 20(1):137. PubMed ID: 36550520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective contracting and channelling patients to preferred providers: A scoping review.
    Bes RE; Curfs EC; Groenewegen PP; de Jong JD
    Health Policy; 2017 May; 121(5):504-514. PubMed ID: 28381338
    [TBL] [Abstract][Full Text] [Related]  

  • 15. To what degree do patients actively choose their healthcare provider at the point of referral by their GP? A video observation study.
    Potappel AJC; Meijers MC; Kloek C; Victoor A; Noordman J; Olde Hartman T; van Dulmen S; de Jong JD
    BMC Fam Pract; 2019 Dec; 20(1):166. PubMed ID: 31787107
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Importance of Choosing a Health Insurance Policy and the Ability to Comprehend That Choice for Citizens in the Netherlands.
    Holst L; Rademakers JJDJM; Brabers AEM; de Jong JD
    Health Lit Res Pract; 2021 Oct; 5(4):e288-e294. PubMed ID: 34756120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. What health plans do people prefer? The trade-off between premium and provider choice.
    Determann D; Lambooij MS; de Bekker-Grob EW; Hayen AP; Varkevisser M; Schut FT; Wit GA
    Soc Sci Med; 2016 Sep; 165():10-18. PubMed ID: 27485728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Managed competition in the Netherlands: Do insurers have incentives to steer on quality?
    Stolper KCF; Boonen LHHM; Schut FT; Varkevisser M
    Health Policy; 2019 Mar; 123(3):293-299. PubMed ID: 30268584
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managed competition in the Netherlands-a qualitative study.
    Heinemann S; Leiber S; Gress S
    Health Policy; 2013 Feb; 109(2):113-21. PubMed ID: 23031431
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Universal mandatory health insurance in the Netherlands: a model for the United States?
    van de Ven WP; Schut FT
    Health Aff (Millwood); 2008; 27(3):771-81. PubMed ID: 18474971
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.